HIF-1 triggers long-lasting glutamate excitotoxicity via system xc- in cerebral ischaemia-reperfusion
What sets Foundayo apart from other GLP-1s is that its a small molecule drug the first GLP-1 in this category that can easily enter the bloodstream through the digestive system, even right after a meal
Recognizing the decreased appetite and potential muscle loss associated with these medications, WW developed a tailored approach
Lilly reported topline results on May 21, 2026, including mean body-weight change of -28.3% at week 80 for the 12 mg arm under the efficacy estimand
Safety protocols are essential to protect both operators and the integrity of the water treatment process
Although the risk of hypoglycemia in GLP-1RAs is low, when used in combination with other hypoglycemic drugs or improper dose adjustment, patients may still have symptoms of hypoglycemia (Wolffenbuttel et al., 2023)